Hepion Pharmaceuticals Inc. (HEPA)
$0.07
$0.00
(7.09%)
As on 03-Sep-2026 10:08EDT
Market cap
$9 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
41.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
1.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.3
-
Face value
--
-
Shares outstanding
90,219,317
10 Years Aggregate
CFO
$-193.21 Mln
EBITDA
$-223.21 Mln
Net Profit
$-212.21 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Hepion Pharmaceuticals (HEPA)
| -- | 47.8 | 13.3 | 3.8 | -94.3 | -86.7 | -79.9 |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Hepion Pharmaceuticals (HEPA)
| -85.3 | -46.1 | -73.7 | -47.9 | -59.1 | -72.8 | -90.1 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Hepion Pharmaceuticals (HEPA)
|
0.1 | 8.6 | 0.0 | -3.2 | -- | -161.6 | -- | 41.9 |
| 86.5 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 271.1 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 74.0 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 59.1 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 110.8 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 371.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 542.6 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 593.4 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 355.2 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Hepion Pharmaceuticals (HEPA)
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It developed Rencofilstat, a therapeutic... drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden; and titers of HBV, HCV, and HDV. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Morristown, New Jersey. Read more
-
Interim CEO & CFO
Mr. John T. Cavan
-
Interim CEO & CFO
Mr. John T. Cavan
-
Headquarters
Morristown, NJ
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Hepion Pharmaceuticals (HEPA)
What is the current share price of Hepion Pharmaceuticals Inc (HEPA) Today?
The share price of Hepion Pharmaceuticals Inc (HEPA) is $0.07 (NASDAQ) as of 03-Sep-2026 10:08 EDT. Hepion Pharmaceuticals Inc (HEPA) has given a return of -94.31% in the last 3 years.
What is the current PB & PE ratio of Hepion Pharmaceuticals Inc (HEPA)?
Since, TTM earnings of Hepion Pharmaceuticals Inc (HEPA) is negative, P/E ratio is not available.
The P/B ratio of Hepion Pharmaceuticals Inc (HEPA) is 41.86 times as on 28-Aug-2026, a 708 premium to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-- |
-- |
2024 |
0.00 |
-0.04 |
2023 |
-0.01 |
0.04 |
2022 |
-0.05 |
0.05 |
2021 |
-0.27 |
0.09 |
What is the 52 Week High and Low of Hepion Pharmaceuticals Inc (HEPA)?
The 52-week high and low of Hepion Pharmaceuticals Inc (HEPA) are Rs 0.11 and Rs 0.04 as of 04-Sep-2026.
What is the market cap of Hepion Pharmaceuticals Inc (HEPA)?
Hepion Pharmaceuticals Inc (HEPA) has a market capitalisation of $ 9 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Hepion Pharmaceuticals Inc (HEPA)?
Before investing in Hepion Pharmaceuticals Inc (HEPA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.